2025-01-07 |
2025-01-03 |
V
Verkauf
|
Firmani Lori
Interim CFO
Führungsperson
|
261
-36.0%
5,63
1.469 USD
|
261
-36.0%
|
5,63
|
1.469 USD
|
|
2025-01-07 |
2025-01-03 |
V
Verkauf
|
Schambye Hans T.
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
1.341
-28.3%
5,60
7.510 USD
|
1.341
-28.3%
|
5,60
|
7.510 USD
|
|
2025-01-07 |
2025-01-03 |
V
Verkauf
|
Winslow Garrett
General Counsel
Führungsperson
|
471
-31.8%
5,60
2.638 USD
|
471
-31.8%
|
5,60
|
2.638 USD
|
|
2023-08-17 |
2023-08-15 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
535.534
-26.2%
0,75
401.651 USD
|
535.534
-26.2%
|
0,75
|
401.651 USD
|
|
2023-08-17 |
2023-08-15 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
248.819
-28.3%
0,75
186.614 USD
|
248.819
-28.3%
|
0,75
|
186.614 USD
|
|
2023-08-17 |
2023-08-15 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
38.327
-28.3%
0,75
28.745 USD
|
38.327
-28.3%
|
0,75
|
28.745 USD
|
|
2023-08-02 |
2023-07-31 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
153.078
-6.8%
3,00
459.234 USD
|
153.078
-6.8%
|
3,00
|
459.234 USD
|
|
2023-08-02 |
2023-07-31 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
29.700
-3.3%
3,00
89.100 USD
|
29.700
-3.3%
|
3,00
|
89.100 USD
|
|
2023-08-02 |
2023-07-31 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
26.622
-16.4%
3,00
79.866 USD
|
26.622
-16.4%
|
3,00
|
79.866 USD
|
|
2023-07-27 |
2023-07-25 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
26.700
-1.2%
2,92
77.964 USD
|
26.700
-1.2%
|
2,92
|
77.964 USD
|
|
2023-07-27 |
2023-07-25 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
4.700
-0.5%
2,92
13.724 USD
|
4.700
-0.5%
|
2,92
|
13.724 USD
|
|
2023-07-27 |
2023-07-25 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
7.800
-4.6%
2,92
22.776 USD
|
7.800
-4.6%
|
2,92
|
22.776 USD
|
|
2023-07-17 |
2023-07-13 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
132.100
-5.5%
2,40
317.040 USD
|
132.100
-5.5%
|
2,40
|
317.040 USD
|
|
2023-07-17 |
2023-07-13 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
52.800
-5.5%
2,40
126.720 USD
|
52.800
-5.5%
|
2,40
|
126.720 USD
|
|
2023-07-17 |
2023-07-13 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
9.800
-5.5%
2,40
23.520 USD
|
9.800
-5.5%
|
2,40
|
23.520 USD
|
|
2023-04-17 |
2023-04-17 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
8.878
-0.4%
1,97
17.490 USD
|
8.878
-0.4%
|
1,97
|
17.490 USD
|
|
2023-04-17 |
2023-04-17 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
3.551
-0.4%
1,97
6.995 USD
|
3.551
-0.4%
|
1,97
|
6.995 USD
|
|
2023-04-17 |
2023-04-17 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
660
-0.4%
1,97
1.300 USD
|
660
-0.4%
|
1,97
|
1.300 USD
|
|
2023-04-17 |
2023-04-14 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
28.110
-1.1%
1,86
52.285 USD
|
28.110
-1.1%
|
1,86
|
52.285 USD
|
|
2023-04-17 |
2023-04-14 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
11.245
-1.1%
1,86
20.916 USD
|
11.245
-1.1%
|
1,86
|
20.916 USD
|
|
2023-04-17 |
2023-04-14 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
2.091
-1.1%
1,86
3.889 USD
|
2.091
-1.1%
|
1,86
|
3.889 USD
|
|
2023-04-17 |
2023-04-13 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
9.459
-0.4%
1,82
17.215 USD
|
9.459
-0.4%
|
1,82
|
17.215 USD
|
|
2023-04-17 |
2023-04-13 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
3.784
-0.4%
1,82
6.887 USD
|
3.784
-0.4%
|
1,82
|
6.887 USD
|
|
2023-04-17 |
2023-04-13 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
703
-0.4%
1,82
1.279 USD
|
703
-0.4%
|
1,82
|
1.279 USD
|
|
2023-04-12 |
2023-04-12 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
1.603
-0.1%
1,81
2.901 USD
|
1.603
-0.1%
|
1,81
|
2.901 USD
|
|
2023-04-12 |
2023-04-12 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
641
-0.1%
1,81
1.160 USD
|
641
-0.1%
|
1,81
|
1.160 USD
|
|
2023-04-12 |
2023-04-12 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
119
-0.1%
1,81
215 USD
|
119
-0.1%
|
1,81
|
215 USD
|
|
2023-04-12 |
2023-04-11 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
9.459
-0.4%
1,82
17.215 USD
|
9.459
-0.4%
|
1,82
|
17.215 USD
|
|
2023-04-12 |
2023-04-11 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
3.784
-0.4%
1,82
6.887 USD
|
3.784
-0.4%
|
1,82
|
6.887 USD
|
|
2023-04-12 |
2023-04-11 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
703
-0.4%
1,82
1.279 USD
|
703
-0.4%
|
1,82
|
1.279 USD
|
|
2023-04-12 |
2023-04-10 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
34.745
-1.4%
1,79
62.194 USD
|
34.745
-1.4%
|
1,79
|
62.194 USD
|
|
2023-04-12 |
2023-04-10 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
13.899
-1.4%
1,79
24.879 USD
|
13.899
-1.4%
|
1,79
|
24.879 USD
|
|
2023-04-12 |
2023-04-10 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
2.584
-1.4%
1,79
4.625 USD
|
2.584
-1.4%
|
1,79
|
4.625 USD
|
|
2023-04-07 |
2023-04-06 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
6.558
-0.3%
2,00
13.116 USD
|
6.558
-0.3%
|
2,00
|
13.116 USD
|
|
2023-04-07 |
2023-04-06 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
2.620
-0.3%
2,00
5.240 USD
|
2.620
-0.3%
|
2,00
|
5.240 USD
|
|
2023-04-07 |
2023-04-06 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
487
-0.3%
2,00
974 USD
|
487
-0.3%
|
2,00
|
974 USD
|
|
2023-04-07 |
2023-04-05 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
63.058
-2.4%
2,18
137.466 USD
|
63.058
-2.4%
|
2,18
|
137.466 USD
|
|
2023-04-07 |
2023-04-05 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
25.220
-2.4%
2,18
54.980 USD
|
25.220
-2.4%
|
2,18
|
54.980 USD
|
|
2023-04-07 |
2023-04-05 |
V
Verkauf
|
ORBIMED ADVISORS LLC
Large shareholder
|
4.687
-2.4%
2,18
10.218 USD
|
4.687
-2.4%
|
2,18
|
10.218 USD
|
|
2022-03-23 |
2022-03-22 |
K
Kauf
|
Schambye Hans T.
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
5.000
+10.5%
2,15
10.750 USD
|
5.000
+10.5%
|
2,15
|
10.750 USD
|
|
2022-03-23 |
2022-03-22 |
K
Kauf
|
Lindmark Bertil
Chief Medical Officer
Führungsperson
|
14.604
+730.2%
2,16
31.545 USD
|
14.604
+730.2%
|
2,16
|
31.545 USD
|
|
2021-12-06 |
2021-12-03 |
K
Kauf
|
Freve Jonathan
Chief Financial Officer
Führungsperson
|
4.000
+50.0%
2,49
9.960 USD
|
4.000
+50.0%
|
2,49
|
9.960 USD
|
|
2021-12-06 |
2021-12-03 |
K
Kauf
|
Winslow Garrett
General Counsel
Führungsperson
|
2.000
+100.0%
2,48
4.960 USD
|
2.000
+100.0%
|
2,48
|
4.960 USD
|
|
2021-11-10 |
2021-11-09 |
K
Kauf
|
Schambye Hans T.
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
4.500
+10.5%
3,50
15.750 USD
|
4.500
+10.5%
|
3,50
|
15.750 USD
|
|
2021-11-09 |
2021-11-08 |
K
Kauf
|
Freve Jonathan
Chief Financial Officer
Führungsperson
|
3.000
+60.0%
3,40
10.200 USD
|
3.000
+60.0%
|
3,40
|
10.200 USD
|
|
2021-06-28 |
2021-06-28 |
K
Kauf
|
Lindmark Bertil
Chief Medical Officer
Führungsperson
|
2.000
+inf%
5,26
10.520 USD
|
2.000
+inf%
|
5,26
|
10.520 USD
|
|
2021-06-24 |
2021-06-24 |
K
Kauf
|
Schambye Hans T.
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
3.000
+7.5%
5,11
15.330 USD
|
3.000
+7.5%
|
5,11
|
15.330 USD
|
|
2020-11-04 |
2020-11-02 |
K
Kauf
|
Novo Holdings A/S
Large shareholder
|
333.333
+15.4%
15,00
4.999.995 USD
|
333.333
+15.4%
|
15,00
|
4.999.995 USD
|
|
2020-11-04 |
2020-11-02 |
K
Kauf
|
Khuong Chau Quang
Nicht geschäftsführender Verwaltungsratsmitglied
Large shareholder
|
209.500
+25.5%
15,00
3.142.500 USD
|
209.500
+25.5%
|
15,00
|
3.142.500 USD
|
|
2020-11-04 |
2020-11-02 |
K
Kauf
|
Khuong Chau Quang
Nicht geschäftsführender Verwaltungsratsmitglied
Large shareholder
|
523.833
+25.5%
15,00
7.857.495 USD
|
523.833
+25.5%
|
15,00
|
7.857.495 USD
|
|
2020-11-04 |
2020-11-02 |
K
Kauf
|
Christgau Stephan
Nicht geschäftsführender Verwaltungsratsmitglied
|
66.666
+13.9%
15,00
999.990 USD
|
66.666
+13.9%
|
15,00
|
999.990 USD
|
|
2020-11-04 |
2020-11-02 |
K
Kauf
|
ORBIMED ADVISORS LLC
Nicht geschäftsführender Verwaltungsratsmitglied
Large shareholder
|
209.500
+25.5%
15,00
3.142.500 USD
|
209.500
+25.5%
|
15,00
|
3.142.500 USD
|
|
2020-11-04 |
2020-11-02 |
K
Kauf
|
ORBIMED ADVISORS LLC
Nicht geschäftsführender Verwaltungsratsmitglied
Large shareholder
|
523.833
+25.5%
15,00
7.857.495 USD
|
523.833
+25.5%
|
15,00
|
7.857.495 USD
|
|